Solution
VITRAKVI ORAL SOLUTION 20MG/ML
Summary
VITRAKVI ORAL SOLUTION 20MG/ML — Solution containing larotrectinib (as sulfate). Hong Kong Registration No. HK-66493. Certificate Holder: BAYER HEALTHCARE LIMITED. Date of Registration: 17 Dec, 2019.
Product NameVITRAKVI ORAL SOLUTION 20MG/ML
Registration No.HK-66493
Certificate HolderBAYER HEALTHCARE LIMITED
Holder Address14/F, OXFORD HOUSE, TAIKOO PLACE, 979 KING’S ROAD, QUARRY BAY, HONG KONG
Ingredientslarotrectinib (as sulfate)
Dosage FormSolution
Legal ClassificationPart 1, Schedule 1 & Schedule 3 Poison
Sale RequirementPrescription only Medicines
Date of Registration17 Dec, 2019
ATC codesL01EX12
ATC Classification
ATC level 1
L Antineoplastic and Immunomodulating Agents
All ATC groupsL01
本頁為藥物資料查詢工具，並非藥物廣告、推廣或醫療建議。所有資料取自香港特別行政區衞生署藥物辦公室之公開資料，僅供參考；一切以藥物辦公室官方公布為準。 本頁不提供任何療效、適應症或治療用途之陳述。用藥前請諮詢醫生或註冊藥劑師。 本網站遵守香港法例第 231 章《不良廣告（醫藥）條例》之規管。